Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice skin changes after starting Wegovy, and it can be unsettling when you weren't expecting them. The most commonly reported wegovy skin side effects are mild and linked to the injection site itself — redness, bruising, or a small lump that usually settles within a few days. Wider skin reactions, such as a rash or itching away from the injection site, are less common but do occur. Wegovy (semaglutide) is a prescription-only medicine, and any skin changes that concern you are worth discussing with a clinician, both to get the right explanation and to rule out anything that needs attention. The full side-effect picture for Wegovy is broader than skin alone, and our prescribers go through all of it as part of the consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've just done your third or fourth Wegovy injection, and you glance down to find the spot is red, slightly raised, and tender to touch. It's a familiar scene. Injection-site reactions are listed among the most frequently reported side effects in semaglutide's clinical data, and the NHS medicines page for semaglutide confirms them as a known, expected occurrence rather than a warning sign.
What you're usually seeing is a localised inflammatory response to the needle itself or to the medicine sitting under the skin. Typical signs include redness (erythema), mild swelling, a small firm area, bruising, or itching directly at the site. Most of these settle within two to four days without any treatment. Rotating your injection site each week (abdomen, thigh, upper arm in turn) reduces the chance of any one spot becoming repeatedly irritated. Keeping your pen at room temperature for a few minutes before injecting (it lives in the fridge door between doses, so take it out while you're getting ready) can also make the injection more comfortable and the local reaction milder. If the same area stays hard or inflamed for more than a week, or if the skin breaks down, tell your prescriber.
Bruising is also common, particularly for people on blood thinners or those new to self-injecting. Applying gentle pressure after the injection (without rubbing) helps. Rubbing the site pushes the medicine into a smaller area of tissue and tends to make bruising worse.
A smaller number of people report skin symptoms that have nothing to do with where the needle went in. These include generalised itching, a patchy rash across the trunk or arms, or urticaria (hives). If you're curious about the specific pattern of itching some patients experience, our page on semaglutide and itchy skin goes into more depth on the mechanism and management.
The likely driver in most cases is a mild immune response to semaglutide itself, the body treating an unfamiliar molecule with mild suspicion. GLP-1 receptor agonists are known to affect immune signalling to a small degree, and skin is an organ with plenty of immune-active cells. In practice, most non-injection-site rashes on Wegovy are mild, transient, and resolve without stopping the medicine. Antihistamines can help with itching; your pharmacist or GP can advise on a suitable option that won't interact with anything else you're taking.
Dry skin and some changes in skin texture are occasionally mentioned by people losing weight rapidly, and if you want a fuller picture of how semaglutide can affect the skin beyond the injection site, it's worth reading up before drawing conclusions. Rapid loss of subcutaneous fat changes the mechanical support under the skin and can alter how it looks and feels, something worth bearing in mind as context, not alarm. For a broader overview of what Wegovy involves before starting, our Wegovy guide covers the full picture.
Most skin changes on Wegovy are a nuisance rather than a danger. A few, however, need prompt attention.
A serious allergic reaction (anaphylaxis) is rare but possible with any injectable medicine. Warning signs include a rash that spreads rapidly across the body, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing, dizziness, or a rapid heartbeat. If any of these appear after an injection, call 999 or go to A&E immediately, do not wait to see if it settles. A reaction of this kind typically begins within minutes to an hour of the injection.
A localised skin infection at the injection site also warrants same-day medical attention: signs are spreading redness and warmth, increasing pain, a yellow or green discharge, or fever. This is uncommon when sterile technique is used but can happen, particularly if the injection site is touched repeatedly or the needle is reused.
Persistent, worsening or unexplained rashes that don't respond to antihistamines after a few days should be reviewed by a GP or dermatologist rather than waiting to see if they fade. Photographs taken over several days are useful evidence. The MHRA wants to hear about skin reactions that seem serious or unexpected, you can file a report at any time through the Yellow Card scheme, and your report contributes to the national safety picture for these medicines.
For more detail on rash patterns specifically, our dedicated page on Wegovy rash covers what different presentations look like and what they tend to mean.
Skin reactions are part of every clinical conversation about Wegovy at nume. Before any prescription is issued, a GPhC-registered Independent Prescriber reviews your health history (including any existing skin conditions, allergies or sensitivities) as part of the same-day clinical assessment. This matters because some pre-existing conditions, or a history of drug hypersensitivity, can change how a prescriber weighs the suitability of semaglutide for you.
If you develop skin changes after starting treatment, you're not left to guess. Our aftercare team is available seven days a week, and questions about whether a reaction is expected or needs escalating are exactly the kind of thing we're there for. People who are sensitive about their skin sometimes wonder whether Wegovy is the right option, that's a question worth exploring properly rather than assuming the answer either way. If you're considering treatment and want to understand what to expect, the free consultation is the right starting point; eligibility and any specific concerns, including skin history, are discussed there.
For context on how Wegovy sits alongside other options, our weight-loss treatment overview is a useful read before you decide.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.